<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35256450</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID - protocol for a mixed-methods study.</ArticleTitle><Pagination><StartPage>e060826</StartPage><MedlinePgn>e060826</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e060826</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-060826</ELocationID><Abstract><AbstractText Label="INTRODUCTION">As the prevalence of Long COVID increases, there is a critical need for a comprehensive assessment of disability. Our aims are to: (1) characterise disability experiences among people living with Long COVID in Canada, UK, USA and Ireland; and (2) develop a patient-reported outcome measure to assess the presence, severity and episodic nature of disability with Long COVID.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">In phase 1, we will conduct semistructured interviews with adults living with Long COVID to explore experiences of disability (dimensions, uncertainty, trajectories, influencing contextual factors) and establish an episodic disability (ED) framework in the context of Long COVID (n~10&#x2009;each country). Using the conceptual framework, we will establish the Long COVID Episodic Disability Questionnaire (EDQ). In phase 2, we will examine the validity (construct, structural) and reliability (internal consistency, test-retest) of the EDQ for use in Long COVID. We will electronically administer the EDQ and four health status criterion measures with adults living with Long COVID, and readminister the EDQ 1&#x2009;week later (n~170&#x2009;each country). We will use Rasch analysis to refine the EDQ, and confirm structural and cross-cultural validity. We will calculate Cronbach's alphas (internal consistency reliability), and intraclass correlation coefficients (test-retest reliability), and examine correlations for hypotheses theorising relationships between EDQ and criterion measure scores (construct validity). Using phase 2 data, we will characterise the profile of disability using structural equation modelling techniques to examine relationships between dimensions of disability and the influence of intrinsic and extrinsic contextual factors. This research involves an academic-clinical-community partnership building on foundational work in ED measurement, Long COVID and rehabilitation.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">This study was approved by the University of Toronto Research Ethics Board. Knowledge translation will occur with community collaborators in the form of presentations and publications in open access peer-reviewed journals and presentations.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>O'Brien</LastName><ForeName>Kelly K</ForeName><Initials>KK</Initials><Identifier Source="ORCID">0000-0002-1632-6537</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada kelly.obrien@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rehabiltation Sciences Institute (RSI), University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long COVID Physio, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brown</LastName><ForeName>Darren A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-4956-243X</Identifier><AffiliationInfo><Affiliation>Therapies Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long COVID Physio, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergin</LastName><ForeName>Colm</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6651-1132</Identifier><AffiliationInfo><Affiliation>Department of Genitourinary and Infectious Diseases (GUIDE Clinic), St. James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trinity College Dublin, School of Medicine, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erlandson</LastName><ForeName>Kristine M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0003-0808-6729</Identifier><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vera</LastName><ForeName>Jaime H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-1165-0573</Identifier><AffiliationInfo><Affiliation>Brighton and Sussex Medical School, University of Sussex Brighton, Brighton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avery</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8431-5143</Identifier><AffiliationInfo><Affiliation>University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carusone</LastName><ForeName>Soo Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-3977-0523</Identifier><AffiliationInfo><Affiliation>McMaster Collaborative for Health and Aging, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-8332-0744</Identifier><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulding</LastName><ForeName>Susie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>COVID Long-Haulers Support Group Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9653-8689</Identifier><AffiliationInfo><Affiliation>Cicely Saunders Institute of Palliative Care, Policy &amp; Rehabilitation, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCorkell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Long COVID Support, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Larry</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Long COVID Physio, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St Clair-Sullivan</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannan</LastName><ForeName>Ciaran</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Genitourinary and Infectious Diseases (GUIDE Clinic), St. James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trinity College Dublin, School of Medicine, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roche</LastName><ForeName>Niamh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Long COVID Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stokes</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Long COVID Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayle</LastName><ForeName>Patriic</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5014-0795</Identifier><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG054366</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003210" MajorTopicYN="N">Concept Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV &amp; AIDS</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword><Keyword MajorTopicYN="N">rehabilitation medicine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35256450</ArticleId><ArticleId IdType="pmc">PMC8905414</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-060826</ArticleId><ArticleId IdType="pii">bmjopen-2022-060826</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE) . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020. Available: https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2021. 10.1016/S1473-3099(21)00703-9. [Epub ahead of print: 21 Dec 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med 2021;268:113426. 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021;4:e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo FR, Waddell LA, Cheung AM. Prevalence of long-term effects in individuals diagnosed with COVID-19: a living systematic review. medRxiv 2021. 10.1101/2021.06.03.21258317</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.03.21258317</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv 2021. 10.1101/2021.06.28.21259452</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of Postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 2021;4:e2128568. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al. . Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, et al. . Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med 2021;19:249. 10.1186/s12916-021-02115-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02115-0</ArticleId><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021;27:1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, et al. . Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil 2022;101:48&#x2013;52. 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research (NIHR) . Living with COVID19: second review, 2021. Available: https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</Citation></Reference><Reference><Citation>Brown D, Oller D, Hassell H. Physical therapists living with long COVID, part 1: defining the Indefinable. JOSPT
2021. 
https://www.jospt.org/do/</Citation></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N. In the wake of the pandemic: preparing for long COVID: policy brief 39, 2021. Available: https://apps.who.int/iris/bitstream/handle/10665/339629/Policy-brief-39-1997-8073-eng.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner C, Lokugamage AU, Molokhia M. Covid-19: prolonged and relapsing course of illness has implications for returning workers, 2020. Available: https://blogs.bmj.com/bmj/2020/06/23/covid-19-prolonged-and-relapsing-course-of-illness-has-implications-for-returning-workers/</Citation></Reference><Reference><Citation>Pantelic M, Alwan N. The stigma is real for people living with long covid. thebmjopinion 2021.</Citation></Reference><Reference><Citation>Power K. The COVID-19 pandemic has increased the care burden of women and families. Sustainability: Science, Practice, and Policy 2020;16:67&#x2013;73.</Citation></Reference><Reference><Citation>Wenham C, Smith J, Morgan R, et al. . COVID-19: the gendered impacts of the outbreak. Lancet 2020;395:846&#x2013;8. 10.1016/S0140-6736(20)30526-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30526-2</ArticleId><ArticleId IdType="pmc">PMC7124625</ArticleId><ArticleId IdType="pubmed">32151325</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19: middle aged women face greater risk of debilitating long term symptoms. BMJ 2021;372:n829. 10.1136/bmj.n829</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 November 2021. estimates of the prevalence of self-reported long COVID and associated activity limitation, using UK coronavirus (COVID-19) infection survey data, 2021. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1july2021 [Accessed 1 Nov 2021].</Citation></Reference><Reference><Citation>Vahidy FS, Pan AP, Ahnstedt H, et al. . Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One 2021;16:e0245556. 10.1371/journal.pone.0245556</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245556</ArticleId><ArticleId IdType="pmc">PMC7806140</ArticleId><ArticleId IdType="pubmed">33439908</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021;93:1013&#x2013;22. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430&#x2013;6. 10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Conte C, Lanzani C, et al. . Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study. PLoS One 2020;15:e0239570. 10.1371/journal.pone.0239570</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239570</ArticleId><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokugamage A, Rayner C, Simpson F. We have heard your message about long covid and we will act, says WHO, 2020. Thebmjopinion. Available: https://blogs.bmj.com/bmj/2020/09/03/we-have-heard-your-message-about-long-covid-and-we-will-act-says-who/</Citation></Reference><Reference><Citation>The Lancet . Understanding long COVID: a modern medical challenge. Lancet 2021;398:725. 10.1016/S0140-6736(21)01900-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01900-0</ArticleId><ArticleId IdType="pmc">PMC8389978</ArticleId><ArticleId IdType="pubmed">34454656</ArticleId></ArticleIdList></Reference><Reference><Citation>World Physiotherapy . World physiotherapy response to COVID-19. Safe rehabilitation approaches for people living with long COVID: physical activity and exercise, 2021. Available: https://world.physio/sites/default/files/2021-07/Briefing-Paper-9-Long-Covid-FINAL-English-202107.pdf</Citation></Reference><Reference><Citation>World Health Organization . Rehabilitation needs of people recovering from COVID-19, 2021. Available: https://www.who.int/publications/m/item/WHO-2019-nCoV-Sci_Brief-Rehabilitation-2021.1 [Accessed 31 Dec 2021].</Citation></Reference><Reference><Citation>World Health Organization . COVID-19 clinical management living guidance, 2021.</Citation></Reference><Reference><Citation>Altiery De Jes&#xfa;s VV, Alwan N, Callard F. Listening to Long COVID: Epistemic Injustice and COVID-19 morbidity. OSF Preprints, 2021. Available: https://osf.io/tfbnd/</Citation></Reference><Reference><Citation>Brown DA, O'Brien KK, Josh J, et al. . Six lessons for COVID-19 rehabilitation from HIV rehabilitation. Phys Ther 2020;100:1906&#x2013;9. 10.1093/ptj/pzaa142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzaa142</ArticleId><ArticleId IdType="pmc">PMC7454859</ArticleId><ArticleId IdType="pubmed">32737967</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, et al. . Long COVID guidelines need to reflect lived experience. Lancet 2021;397:455&#x2013;7. 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021;372:n136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME. Characteristics of long COVID: findings from a social media survey. medRxiv 2021. 10.1101/2021.03.21.21253968</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.21.21253968</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O'Brien KK. Conceptualising long COVID as an episodic health condition. BMJ Glob Health 2021;6. 10.1136/bmjgh-2021-007004</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-007004</ArticleId><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Bayoumi AM, Strike C, et al. . Exploring disability from the perspective of adults living with HIV/AIDS: development of a conceptual framework. Health Qual Life Outcomes 2008;6:76. 10.1186/1477-7525-6-76</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-6-76</ArticleId><ArticleId IdType="pmc">PMC2572592</ArticleId><ArticleId IdType="pubmed">18834538</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon P, O'Brien KK, Nixon S, et al. . Trajectories of episodic disability in people aging with HIV: a longitudinal qualitative study. J Int Assoc Provid AIDS Care 2018;17:2325958218759210. 10.1177/2325958218759210</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325958218759210</ArticleId><ArticleId IdType="pmc">PMC6748469</ArticleId><ArticleId IdType="pubmed">29464973</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Davis AM, Strike C, et al. . Putting episodic disability into context: a qualitative study exploring factors that influence disability experienced by adults living with HIV/AIDS. J Int AIDS Soc 2009;12:5. 10.1186/1758-2652-12-30</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2652-12-30</ArticleId><ArticleId IdType="pmc">PMC2788343</ArticleId><ArticleId IdType="pubmed">19900284</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Hanna S, Gardner S, et al. . Validation of the episodic disability framework with adults living with HIV. Disabil Rehabil 2014;36:319&#x2013;29. 10.3109/09638288.2013.793408</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2013.793408</ArticleId><ArticleId IdType="pubmed">23688295</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Bergin C, Solomon P, et al. . Cross-cultural applicability of the episodic disability framework with adults living with HIV in Ireland: a qualitative study. Disabil Rehabil 2021;43:229&#x2013;40. 10.1080/09638288.2019.1621395</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2019.1621395</ArticleId><ArticleId IdType="pubmed">31161816</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . World Health Organizations disability assessment schedule II (WHO-DAS-II) 2001.</Citation></Reference><Reference><Citation>Sivan M, Halpin S, Gee J, et al. . Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). ACNR 2020;19:14&#x2013;17. 10.47795/NELE5960</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/NELE5960</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Bayoumi AM, King K, et al. . Community engagement in health status instrument development: experience with the HIV disability questionnaire. Prog Community Health Partnersh 2014;8:549&#x2013;59. 10.1353/cpr.2014.0071</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/cpr.2014.0071</ArticleId><ArticleId IdType="pubmed">25727988</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Bayoumi AM, Stratford P, et al. . Which dimensions of disability does the HIV disability questionnaire (HDQ) measure? a factor analysis. Disabil Rehabil 2015;37:1193&#x2013;201. 10.3109/09638288.2014.949358</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2014.949358</ArticleId><ArticleId IdType="pubmed">25116628</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Solomon P, Bayoumi AM. Measuring disability experienced by adults living with HIV: assessing construct validity of the HIV disability questionnaire using confirmatory factor analysis. BMJ Open 2014;4:e005456. 10.1136/bmjopen-2014-005456</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005456</ArticleId><ArticleId IdType="pmc">PMC4156819</ArticleId><ArticleId IdType="pubmed">25180054</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, Simmons B, Boffito M, et al. . Evaluation of the psychometric properties of the HIV disability questionnaire among adults living with HIV in the United Kingdom: a cross-sectional self-report measurement study. PLoS One 2019;14:e0213222. 10.1371/journal.pone.0213222</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213222</ArticleId><ArticleId IdType="pmc">PMC6619602</ArticleId><ArticleId IdType="pubmed">31291243</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Bayoumi AM, Bereket T, et al. . Sensibility assessment of the HIV disability questionnaire. Disabil Rehabil 2013;35:566&#x2013;77. 10.3109/09638288.2012.702848</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288.2012.702848</ArticleId><ArticleId IdType="pubmed">22816434</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Solomon P, Bergin C, et al. . Reliability and validity of a new HIV-specific questionnaire with adults living with HIV in Canada and ireland: the HIV disability questionnaire (HDQ). Health Qual Life Outcomes 2015;13:124. 10.1186/s12955-015-0310-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-015-0310-9</ArticleId><ArticleId IdType="pmc">PMC4542093</ArticleId><ArticleId IdType="pubmed">26263898</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Kietrys D, Galantino ML, et al. . Reliability and validity of the HIV disability questionnaire (HDQ) with adults living with HIV in the United States. J Int Assoc Provid AIDS Care 2019;18:2325958219888461:232595821988846. 10.1177/2325958219888461</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325958219888461</ArticleId><ArticleId IdType="pmc">PMC6880031</ArticleId><ArticleId IdType="pubmed">31769326</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Dzingina M, Harding R, et al. . Developing a short-form version of the HIV disability questionnaire (SF-HDQ) for use in clinical practice: a Rasch analysis. Health Qual Life Outcomes 2021;19:6. 10.1186/s12955-020-01643-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01643-2</ArticleId><ArticleId IdType="pmc">PMC7789190</ArticleId><ArticleId IdType="pubmed">33407538</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Brown DA, Corbett C, et al. . AIDSImpact special issue - broadening the lens: recommendations from rehabilitation in chronic disease to advance healthy ageing with HIV. AIDS Care 2020;32:65&#x2013;73. 10.1080/09540121.2020.1739203</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09540121.2020.1739203</ArticleId><ArticleId IdType="pubmed">32208741</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon P, O'Brien KK, Baxter L, et al. . Community involvement in development of evidence-informed recommendations for rehabilitation for older adults living with HIV. Prog Community Health Partnersh 2016;10:83&#x2013;8. 10.1353/cpr.2016.0008</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/cpr.2016.0008</ArticleId><ArticleId IdType="pubmed">27018357</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID long Haulers support group Canada (Goulding), 2021. Available: https://covidlonghaulcanada.com/</Citation></Reference><Reference><Citation>Long COVID Support , 2021. Available: https://www.longcovid.org/</Citation></Reference><Reference><Citation>Long COVID Physio. Available: https://longcovid.physio/https://www.physio-pedia.com/Long_COVID2021</Citation></Reference><Reference><Citation>Patient-Led Research Collaborative , 2021. Available: https://patientresearchcovid19.com/</Citation></Reference><Reference><Citation>Long COVID Ireland. Available: https://www.longcovidireland.org/ [Accessed 31 Dec 2021].</Citation></Reference><Reference><Citation>O'Brien KK, Solomon P, Worthington C, et al. . Considerations for conducting web-based survey research with people living with human immunodeficiency virus using a community-based participatory approach. J Med Internet Res 2014;16:e81. 10.2196/jmir.3064</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.3064</ArticleId><ArticleId IdType="pmc">PMC3971118</ArticleId><ArticleId IdType="pubmed">24642066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillman DA. Mail and Internet surveys: the tailored design method-2007 update with new Internet, visual, and mixed-mode guide. John Wiley &amp; Sons, 2011.</Citation></Reference><Reference><Citation>EuroQuol . EQ-5D, 2021. Available: https://euroqol.org/eq-5d-instruments/ [Accessed 12 Nov 2021].</Citation></Reference><Reference><Citation>Mundt JC, Marks IM, Shear MK, et al. . The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry 2002;180:461&#x2013;4. 10.1192/bjp.180.5.461</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.180.5.461</ArticleId><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualtrics [program]. Provo, Utah, USA, 2017.</Citation></Reference><Reference><Citation>O'Connor RJ, Preston N, Parkin A. The COVID-19 Yorkshire rehabilitation scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort. J Med Virol 2021. 10.1002/jmv.27415</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27415</ArticleId><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020;81:e4&#x2013;6. 10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277&#x2013;88. 10.1177/1049732305276687</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732305276687</ArticleId><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>Flicker S, Nixon SA. The DEPICT model for participatory qualitative health promotion research analysis piloted in Canada, Zambia and South Africa. Health Promot Int 2015;30:616&#x2013;24. 10.1093/heapro/dat093</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/heapro/dat093</ArticleId><ArticleId IdType="pmc">PMC4542917</ArticleId><ArticleId IdType="pubmed">24418997</ArticleId></ArticleIdList></Reference><Reference><Citation>Dierckx de Casterl&#xe9; B, Gastmans C, Bryon E, et al. . QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud 2012;49:360&#x2013;71. 10.1016/j.ijnurstu.2011.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2011.09.012</ArticleId><ArticleId IdType="pubmed">21996649</ArticleId></ArticleIdList></Reference><Reference><Citation>NVivo qualitative data analysis software. Version 11. [program] 2017.</Citation></Reference><Reference><Citation>Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007;57:1358&#x2013;62. 10.1002/art.23108</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23108</ArticleId><ArticleId IdType="pubmed">18050173</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant A, Penta M, Tesio L, et al. . Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Med Care 2004;42:I37&#x2013;48. 10.1097/01.mlr.0000103529.63132.77</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000103529.63132.77</ArticleId><ArticleId IdType="pubmed">14707754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusch T, Lowry PB, Mair P, et al. . Breaking free from the limitations of classical test theory: developing and measuring information systems scales using item response theory. Inf Manage 2017;54:189&#x2013;203. 10.1016/j.im.2016.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.im.2016.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelleri JC, Jason Lundy J, Hays RD. Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures. Clin Ther 2014;36:648&#x2013;62. 10.1016/j.clinthera.2014.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.04.006</ArticleId><ArticleId IdType="pmc">PMC4096146</ArticleId><ArticleId IdType="pubmed">24811753</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnally JC, Bernstein IH. Psychometric theory. 3rd edn. New York: McGraw-Hill, 1978.</Citation></Reference><Reference><Citation>Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004;7(Suppl 1):S22&#x2013;6. 10.1111/j.1524-4733.2004.7s106.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2004.7s106.x</ArticleId><ArticleId IdType="pubmed">15367240</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier JE, Rowen D, Mavranezouli I, et al. . Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technol Assess 2012;16:1&#x2013;114. 10.3310/hta16320</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta16320</ArticleId><ArticleId IdType="pubmed">22832015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310:170. 10.1136/bmj.310.6973.170</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6973.170</ArticleId><ArticleId IdType="pmc">PMC2548561</ArticleId><ArticleId IdType="pubmed">7833759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant A, Pallant JF. Unidimensionality matters. Rasch Meas Trans 2006;20:1048&#x2013;51.</Citation></Reference><Reference><Citation>Perruccio AV, Stefan Lohmander L, Canizares M, et al. . The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008;16:542&#x2013;50. 10.1016/j.joca.2007.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2007.12.014</ArticleId><ArticleId IdType="pubmed">18294869</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson N, Alonso J, Burnam A, et al. . Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193&#x2013;205. 10.1023/a:1015291021312</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1015291021312</ArticleId><ArticleId IdType="pubmed">12074258</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee CB, Bot SDM, de Boer MR, et al. . Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34&#x2013;42. 10.1016/j.jclinepi.2006.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.03.012</ArticleId><ArticleId IdType="pubmed">17161752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher L. A step-by-step approach to using SAS for factor analysis and structural equation modeling. Cary, NC, USA: SAS Institute Inc, 1994.</Citation></Reference><Reference><Citation>Schumacker RE, Lomax RG. A Beginner&#x2019;s Guide to Structural Equation Modeling. 2nd edn. Lawrence Erlbaum Associates, Inc, 2004.</Citation></Reference><Reference><Citation>Kline RB. Principles and practice of structural equation modeling. 3rd edn. New York, NY: The Guilford Press, 2011.</Citation></Reference><Reference><Citation>LT H, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Methods 1998;3:424&#x2013;53. 10.1037/1082-989X.3.4.424</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.3.4.424</ArticleId></ArticleIdList></Reference><Reference><Citation>LT H, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999;6:1&#x2013;55. 10.1080/10705519909540118</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705519909540118</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown TA. Confirmatory factor analysis for applied research. New York, NY: The Guilford Press, 2006.</Citation></Reference><Reference><Citation>SAS Computer Software 9.3 [program], 2011.</Citation></Reference><Reference><Citation>RUMM2030 [program]. Duncraig, Western Australia, 2018.</Citation></Reference><Reference><Citation>Mplus Version 8.2 [program]. Los Angeles, CA, 2018.</Citation></Reference><Reference><Citation>Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res 2017;27:591&#x2013;608. 10.1177/1049732316665344</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732316665344</ArticleId><ArticleId IdType="pmc">PMC9359070</ArticleId><ArticleId IdType="pubmed">27670770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sample Size and Item Parameter Estimation Precision When Utilizing the One-Parameter &#x201c;Rasch&#x201d; Model Annual Meeting of the Mid-Western Educational Research Association 2015; Evanston, Illinois.</Citation></Reference><Reference><Citation>Canada-International HIV and rehabilitation research collaborative (CIHRRC), 2021. Available: http://cihrrc.ca</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236512</ArticleId><ArticleId IdType="pubmed">32429973</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KK, Solomon P, Ib&#xe1;&#xf1;ez-Carrasco F, et al. . Evolution of an international research collaborative in HIV and rehabilitation: community engaged process, lessons learned, and recommendations. Prog Community Health Partnersh 2018;12:395&#x2013;408. 10.1353/cpr.2018.0065</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/cpr.2018.0065</ArticleId><ArticleId IdType="pubmed">30739894</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G, Long Covid Forum Group . Research priorities for long Covid: refined through an international multi-stakeholder forum. BMC Med 2021;19:84. 10.1186/s12916-021-01947-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini S, Mills J-A, Arienti C, et al. . "Rehabilitation research framework for patients with COVID-19" defined by cochrane rehabilitation and the World Health Organization rehabilitation programme. Arch Phys Med Rehabil 2021;102:1424&#x2013;30. 10.1016/j.apmr.2021.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.02.018</ArticleId><ArticleId IdType="pmc">PMC7948530</ArticleId><ArticleId IdType="pubmed">33716115</ArticleId></ArticleIdList></Reference><Reference><Citation>Citrix . ShareFile, &#xa9;2021 Citrix Systems, Inc, 2021. Available: http://www.sharefile.com/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>